Treatment-experienced patients with moderate to severe atopic dermatitis attained higher efficacy rates on rocatinlimab ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Story Feb. 4 - Kyowa Kirin: The Japanese pharma is letting go ... shrinking its head count by 40% and reassessing the future of Amgen-partnered T-cell engager CX-904 as a way to save cash and ...